{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:58:23Z","timestamp":1649098703293},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T00:00:00Z","timestamp":1311552000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022601","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T20:57:23Z","timestamp":1311627443000},"page":"e22601","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Episodic Therapy for Genital Herpes in Sub-Saharan Africa: A Pooled Analysis from Three Randomized Controlled Trials"],"prefix":"10.1371","volume":"6","author":[{"given":"Helen A.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Paz Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Gresenguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"LeGoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Pepin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Belec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irving F.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Mayaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,7,25]]},"reference":[{"key":"ref1","first-page":"24A","article-title":"Epidemiology of herpes simplex virus type 2 infection in the developing world.","volume":"11","author":"H Weiss","year":"2004","journal-title":"Herpes"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: clinical manifestations, course, and complications.","volume":"98","author":"L Corey","year":"1983","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1001\/jama.1984.03340400031020","article-title":"Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.","volume":"251","author":"RC Reichman","year":"1984","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jama.1984.03350090023017","article-title":"Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.","volume":"252","author":"GJ Mertz","year":"1984","journal-title":"JAMA"},{"key":"ref5","article-title":"Guidelines for the management of sexually transmitted infections","year":"2003"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/OLQ.0b013e3181e212e5","article-title":"Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries.","volume":"37","author":"C Corbell","year":"2010","journal-title":"Sex Transm Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1086\/599991","article-title":"Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.","volume":"200","author":"P Mayaud","year":"2009","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/sti.2009.041814","article-title":"Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi.","volume":"86","author":"S Phiri","year":"2010","journal-title":"Sex Transm Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/605647","article-title":"Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.","volume":"200","author":"G Paz-Bailey","year":"2009","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/20786204.2010.10873926","article-title":"Revision of the national guideline for first-line comprehensive management and control of sexually transmitted infections: what's new and why?","volume":"52","author":"DA Lewis","year":"2010","journal-title":"SA Fam Pract"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data.","volume":"159","author":"G Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"ref12","first-page":"447","article-title":"Genital herpes and human immunodeficiency virus: double trouble.","volume":"82","author":"C Celum","year":"2004","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1056\/NEJMe068302","article-title":"Synergistic copathogens\u2013HIV-1 and HSV-2.","volume":"356","author":"L Corey","year":"2007","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/QAD.0b013e32832e15e8","article-title":"Herpes simplex virus type 2: a key role in HIV incidence.","volume":"23","author":"JR Glynn","year":"2009","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJMoa0800260","article-title":"Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.","volume":"358","author":"D Watson-Jones","year":"2008","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(08)60920-4","article-title":"Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.","volume":"371","author":"C Celum","year":"2008","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa0904849","article-title":"Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.","volume":"362","author":"C Celum","year":"2010","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAI.0b013e3181831832","article-title":"Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand.","volume":"49","author":"EF Dunne","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/sti.2008.031153","article-title":"A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.","volume":"84","author":"FM Cowan","year":"2008","journal-title":"Sex Transm Infect"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/522523","article-title":"Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1\/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.","volume":"196","author":"RA Zuckerman","year":"2007","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QAD.0b013e328326ca62","article-title":"HSV suppression reduces seminal HIV-1 levels in HIV-1\/HSV-2 co-infected men who have sex with men.","volume":"23","author":"RA Zuckerman","year":"2009","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1086\/593214","article-title":"Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2\/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.","volume":"198","author":"JM Baeten","year":"2008","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/651696","article-title":"Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.","volume":"201","author":"C Tanton","year":"2010","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/QAD.0b013e32831db217","article-title":"Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2\/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.","volume":"23","author":"S Delany","year":"2009","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(09)62038-9","article-title":"Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.","volume":"375","author":"JR Lingappa","year":"2010","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/515621","article-title":"Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data.","volume":"178","author":"JP Ioannidis","year":"1998","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/505496","article-title":"Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.","volume":"43","author":"LB Strick","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.7326\/0003-4819-110-11-882","article-title":"Development of clinically recognizable genital lesions among women previously identified as having \u201casymptomatic\u201d herpes simplex virus type 2 infection.","volume":"110","author":"A Langenberg","year":"1989","journal-title":"Ann Intern Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T18:45:58Z","timestamp":1638125158000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022601"}},"subtitle":[],"editor":[{"given":"Rupert","family":"Kaul","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,25]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022601","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,25]]}}}